LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening Hub

Contributed by: GlobeNewswire

Images

GlobeNewswire associated0

Tags

Lumira

More Like This

LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche

Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G Nfl Blood Assay

ADx NeuroSciences and Alamar Biosciences Announce Partnership to Provide Customized Blood-Based Biomarker Assay Solutions to Accelerate Biopharma Clinical Development

PR Newswire associated0

Mindray Expands Its Cardiac Biomarker Portfolio with Cutting-Edge hs-cTnI and NT-proBNP Assays, Empowering Enhanced Cardiovascular Diseases Care

LUMA Vision Co-Founders, CEO Fionn Lahart (right) and Chief Technology Officer Christoph Hennersperger (left). (Photo: Business Wire)

LUMA Vision Announces $22 Million in New Financing to Secure FDA Approval and Advance Development of 4D Cardiac Imaging and Navigation Platform

PR Newswire associated0

SCIENTISTS PIONEER DEVELOPMENT OF MULTI-DISEASE RAPID TESTS AS EDX MEDICAL PLC COMPLETES ACQUISITION OF HUTANO DIAGNOSTICS LTD

Aptar Digital Health’s patient mobile app and HeroTracker® Sense sensor (Photo: Business Wire)

Aptar Digital Health Announces Asthma Clinical Study with Guy’s and St Thomas’ NHS Foundation Trust

Beacon Therapeutics Announces EURETINA 2025 Presentations on 9+-Month Phase 2 DAWN and 36-Month Phase 2 SKYLINE Trial Data for laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP)